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deficiency ameliorates cerulein-induced acute
pancreatitis
Ahmed Bettaieb1, Yannan Xi1, Ellen Hosein1, Nicole Coggins1, Santana Bachaalany1, Florian Wiede2,
Salvador Perez3, Stephen M Griffey4, Juan Sastre3, Tony Tiganis2 and Fawaz G Haj1,5,6*Abstract
Background: Acute pancreatitis (AP) is a common clinical problem whose incidence has been progressively
increasing in recent years. Onset of the disease is trigged by intra-acinar cell activation of digestive enzyme
zymogens that induce autodigestion, release of pro-inflammatory cytokines and acinar cell injury. T-cell protein
tyrosine phosphatase (TCPTP) is implicated in inflammatory signaling but its significance in AP remains unclear.
Results: In this study we assessed the role of pancreatic TCPTP in cerulein-induced AP. TCPTP expression was
increased at the protein and messenger RNA levels in the early phase of AP in mice and rats. To directly determine
whether TCPTP may have a causal role in AP we generated mice with pancreatic TCPTP deletion (panc-TCPTP KO)
by crossing TCPTP floxed mice with Pdx1-Cre transgenic mice. Amylase and lipase levels were lower in
cerulein-treated panc-TCPTP KO mice compared with controls. In addition, pancreatic mRNA and serum
concentrations of the inflammatory cytokines TNFα and IL-6 were lower in panc-TCPTP KO mice. At the molecular
level, panc-TCPTP KO mice exhibited enhanced cerulein-induced STAT3 Tyr705 phosphorylation accompanied by a
decreased cerulein-induced NF-κB inflammatory response, and decreased ER stress and cell death.
Conclusion: These findings revealed a novel role for pancreatic TCPTP in the progression of cerulein-induced AP.
Keywords: Acute pancreatitis, TCPTP, Inflammation, STAT3, Knockout miceBackground
Acute pancreatitis (AP) is often the most common reason
for hospitalization from gastrointestinal diseases in West-
ern countries with an unpredictable clinical course [1,2].
The incidence of AP has been progressively increasing in
recent years in parallel with its risk factors such as duct
obstruction by gallstones, alcohol abuse and obesity [2,3].
Approximately 25% of patients with AP develop a severe
disease course that leads to systemic inflammation and
multiple organ dysfunction with mortality rates of up to
50% [2,4]. The onset of the disease is triggered by acinar
events that involve premature intra-acinar activation of
digestive enzymes such as trypsinogen that induces* Correspondence: fghaj@ucdavis.edu
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unless otherwise stated.autodigestion, the release of pro-inflammatory cytokines
and acinar cell injury [5-7]. AP remains without specific
therapy and understanding the molecular mechanisms
underlying its pathogenesis will aid in therapeutic
intervention.
Several animal models of AP have been generated to
investigate the pathogenesis and to explore potential
therapeutic approaches; one of the most common is
cerulein-induced pancreatitis [8]. Cerulein is an ortholog
of the intestinal hormone cholecystokinin and at high
concentrations causes pancreatic secretion of lipase and
amylase, death of acinar cells, edema formation and the
infiltration of inflammatory cells into the pancreas [9-11],
all of which are also observed in human pancreatitis. The
mechanism of cerulein action involves activation of
NF-κB, the promotion of oxidative stress, and the release
of pro-inflammatory cytokines [12,13]. In addition, ceru-
lein treatment modulates pancreatic protein tyrosinel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tivities [14,15].
The roles of PTPs in AP remain largely unexplored, but
some studies have demonstrated altered PTPs expression
and activity in murine models of AP. Indeed, cerulein-
induced AP in rats is associated with increases in the ex-
pression of SHP1 and SHP2 and changes in the dynamics
of SHP2 subcellular distribution during the early phase of
AP progression [16]. In addition, expression of the endo-
plasmic reticulum (ER)-anchored protein phosphatase
PTP1B is increased in the early phase of cerulein-induced
AP [17]. Although these findings suggest a role for PTPs
in AP, additional investigation into the contribution of
PTPs to the pathogenesis of AP is warranted.
T-cell protein tyrosine phosphatase (TCPTP; encoded
by PTPN2) is a ubiquitously-expressed PTP [18]. Two
splice variants of TCPTP are expressed: a 48 kDa form
which is anchored to the ER by a hydrophobic C-
terminus, and a 45 kDa variant that lacks the hydropho-
bic C-terminus and has access to nuclear and cytosolic
substrates [19-21]. Several substrates of TCPTP have
been identified and include receptor PTKs (RTKs)
[19,22,23], non-receptor PTKs such as c-Src [24] and
Janus family kinases (JAKs) 1/3 [25], and substrates of
PTKs such as signal transducer and activator of tran-
scription (STAT) 1, 3, 5 and 6 [26-30]. Whole-body
TCPTP deficiency in mice leads to hematopoietic defects
and progressive systemic inflammatory disease [31,32].
More recently, tissue-specific TCPTP deletion helped de-
fine the functions of this phosphatase in T cells [33],
muscle [34] and brain [30]. However, the function of
TCPTP in the pancreas remains unresolved. TCPTP is
expressed in the endocrine and exocrine pancreas in
mice with stronger expression in islets than the sur-
rounding exocrine tissue [35]. Genome-wide association
screens identify PTPN2 as a susceptibility gene in the
pathogenesis of type 1 diabetes [36] whereas others re-
port that TCPTP regulates cytokine-induced β-cell apop-
tosis [37,38]. In addition, TCPTP regulates ER stress in
the glucose-responsive MIN6 β-cells and alterations in
pancreatic TCPTP expression may serve as an adaptive
response for the mitigation of chronic ER stress [35].
In the present study, we investigated the effects of pan-
creatic TCPTP deletion on cerulein-induced AP. Alter-
ations in systemic inflammation were determined in
cerulein-treated versus non-treated control and pancreas-
TCPTP knockout mice, and the underlying molecular
mechanism investigated.
Results
TCPTP expression is increased in the early phase of acute
pancreatitis
AP was induced by repetitive intraperitoneal injections of
cerulein, an analog of the secretagogue cholecystokinin,to wild type mice and expression of TCPTP was deter-
mined. Immunoblots of pancreatic lysates demonstrated
increased TCPTP expression upon cerulein administra-
tion (Figure 1A). Expression of the closely related PTP1B
and the SH2 domain-containing phosphatase SHP1 was
increased upon cerulein administration consistent with
published reports [16,17]. In addition, mRNAs of the
genes encoding TCPTP, PTP1B and SHP1, as determined
by real time RT-PCR, were increased in the pancreas
upon cerulein administration (Figure 1B). Similarly, pan-
creatic TCPTP, SHP1 and PTP1B protein expression was
increased in a taurocholate-induced AP rat model [39,40]
(Figure 1C). Together, these findings demonstrate that
AP is associated with increases in TCPTP at the level of
both mRNA and protein.
Ablation of pancreatic TCPTP mitigates cerulein-induced
pancreatitis
The increased expression of TCPTP upon cerulein ad-
ministration prompted us to investigate the role of this
phosphatase in AP. To that end, we crossed TCPTPfl/fl
mice to those expressing Cre recombinase under the con-
trol of pancreatic and duodenal homeobox 1 (Pdx1) pro-
moter to generate mice lacking TCPTP in the (endocrine
and exocrine) pancreas [41]. Pancreatic TCPTP knockout
mice (hereafter referred to as panc-TCPTP KO) survived
to adulthood and did not display gross defects in pancre-
atic development. Immunoblot analysis of total pancreas
lysates demonstrated significant reduction in TCPTP ex-
pression in panc-TCPTP KO mice compared with con-
trols (Figure 2A). In addition, TCPTP expression was
unchanged in other tissues such as hypothalamus, liver,
muscle and adipose tissue (data not shown, and Xi et al.,
submitted). Similar to wild type mice, panc-TCPTP KO
mice exhibited increased expression of SHP1 and
PTP1B upon cerulein administration (Additional file 1:
Figure S1). Thus, this mouse model provides efficient
TCPTP deletion in the pancreas enabling the determin-
ation of TCPTP contribution to pancreatitis.
To clarify the significance of TCPTP during AP, we
determined the severity of cerulein-induced pancreatitis
in control and panc-TCPTP KO mice. Mice were fasted
overnight and cerulein (50 μg/kg body weight) adminis-
tered over 12 h and analyses undertaken 2 h later.
Histological analysis (Hematoxylin and Eosin staining)
evaluating pathologic changes including edema, cell
vacuolation and necrosis did not reveal any overt differ-
ences between cerulein-treated and untreated mice in
this acute timeframe between treatment and euthanasia
(data not shown). However, serum activities of amylase
and lipase that are commonly used as markers for pan-
creatic disease, particularly AP were significantly differ-
ent between control and panc-TCPTP KO mice with
and without cerulein administration. Under basal
Figure 1 Increased TCPTP expression in acute pancreatitis. A) Total pancreas lysates of wild type mice that were administered saline (control;
Ctr; n = 9) or cerulein (Cer; n = 12) immunoblotted for TCPTP, PTP1B, SHP1 and Tubulin. Bar graph represents expression of TCPTP, PTP1B and
SHP1 (normalized to Tubulin) and presented as means ± SEM. B) TCPTP, PTP1B and SHP1 expression as assessed by quantitative real time PCR in
the pancreata of wild type mice without (-) (n = 6) and with (+) (n = 8) cerulein administration. For A and B (**; P≤ 0.01) indicates significant
difference between saline- and cerulein-injected mice. C) Total pancreas lysates of rats that were administered saline or taurocholate, sacrificed
after 1 and 6 h then immunoblotted for TCPTP, PTP1B, SHP1 and Tubulin. Bar graph represents expression of TCPTP, PTP1B and SHP1 (normalized
to Tubulin) and presented as means ± SEM. (**; P≤ 0.01) indicates significant difference between saline- and taurocholate-injected rats.
Bettaieb et al. Cell Communication and Signaling 2014, 12:13 Page 3 of 11
http://www.biosignaling.com/content/12/1/13conditions, serum amylase and lipase were comparable
between control and panc-TCPTP KO mice (Figure 2B).
Cerulein administration led to significant increase in
amylase and lipase; however pancreatic TCPTP deficiency
significantly reduced amylase and lipase after cerulein ad-
ministration. Comparable findings were observed in two
independent cohorts of mice. During AP the activation of
NF-κB enhances the release of many pro-inflammatory cy-
tokines such as TNFα, IL-1β and IL-6. TNFα, IL-1β are
considered primary cytokines in AP since they initiate and
propagate most of the consequences of the systemic in-
flammatory response [42,43], while IL-6 mediates the
acute-phase response [44]. Accordingly, pancreatic mRNA
levels of TNFα, IL-6 and IL-1β were increased in control
mice after cerulein administration and this was signifi-
cantly reduced in panc-TCPTP KO (Figure 2C). Similarly,
serum levels of TNFα and IL-6 were increased in control
mice after cerulein administration and this was signifi-
cantly reduced in panc-TCPTP KO (Figure 2D). Together,these data demonstrate that pancreatic TCPTP deficiency
mitigates cerulein-induced AP in mice.
Pancreatic TCPTP deficiency regulates cerulein-induced
STAT3 and MAPKs signaling
To investigate the molecular basis for decreased AP in
panc-TCPTP KO mice, we initially determined tyrosyl
phosphorylation status of STAT3, a bona fide TCPTP
substrate [18,26,29,30]. It is noteworthy that ablation of
pancreatic STAT3 exacerbates cerulein-induced pancrea-
titis and demonstrates a protective effect of STAT3
against pancreatitis [45]. STAT3 is activated by phos-
phorylation at Tyr705 leading to dimerization and re-
location to the nucleus to promote gene expression [46].
Immunoblots of total pancreatic lysates revealed signifi-
cantly increased cerulein-induced STAT3 Tyr705 phos-
phorylation in panc-TCPTP KO mice compared with
controls (Figure 3). Mitogen-activated protein kinases
(MAPKs) including ERK1/2, p38 and JNK1/2 are induced
Figure 2 Pancreatic TCPTP deficiency decreases cerulein-induced pancreatic injury. A) Total pancreas lysates from wild type (WT) and
panc-TCPTP KO (KO) mice were immunoblotted for TCPTP and Tubulin. B) Acute pancreatitis was induced by intraperitoneal injections of cerulein
as detailed in Methods. Serum amylase and lipase were determined in control mice without (n = 9) and with (n = 12) cerulein and in panc-TCPTP
KO mice without (n = 7) and with (n = 9) cerulein. C) TNFα, IL-6 and IL-1β expression (as assessed by quantitative real time PCR) in the pancreata of
control mice without (n = 6) and with (n = 6) cerulein and panc-TCPTP KO mice without (n = 5) and with (n = 5) cerulein. D) Circulating levels of
TNFα and IL-6 in serum of control mice without (n = 6) and with (n = 12) cerulein and panc-TCPTP KO mice without (n = 6) and with (n = 6)
cerulein. (**; P ≤ 0.01) indicates significant difference between saline- and cerulein-injected mice, and (##; P≤ 0.01) indicates significant difference
between WT and KO mice.
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dents [47]. This activation is believed to be a component
of the cellular stress response in the onset of inflamma-
tion in the pancreas. Indeed, cerulein administration led
to increased phosphorylation of ERK1/2, p38 and JNK in
control mice that was significantly lower in panc-TCPTP
KO mice (Figure 3). The decreased MAPK activation is
in keeping with the reduced cerulein-induced AP and in-
flammation in panc-TCPTP KO mice. These findings
demonstrate increased STAT3 phosphorylation and de-
creased MAPKs activation in pancreata of cerulein-
treated panc-TCPTP KO mice.Pancreatic TCPTP deficiency decreases cerulein-induced
NF-κB inflammation, ER stress and cell death
NF-κB is a transcription factor that regulates the inflam-
matory response and plays a crucial role in the patho-
genesis of AP [48,49]. NF-κB is activated early in AP in
leukocytes and pancreatic acinar cells [50]. Pro-
inflammatory cytokines such as TNFα activate the IκB
kinase complex (IKK) (composed of three subunits IKKγ,
IKKα and IKKβ) to phosphorylate inhibitor of NF-κB
(IκB) [51]. IκB phosphorylation triggers its ubiquitina-
tion and subsequent degradation, leading to the dissoci-
ation of NF-κB dimers (typically composed of RelA/p65
Figure 3 Pancreatic TCPTP deficiency regulates cerulein-induced STAT3 and MAPKs signaling. Total pancreas lysates from control without
(n = 9) and with (n = 12) cerulein and panc-TCPTP KO without (n = 7) and with (n = 9) cerulein were immunoblotted for pSTAT3, pERK1/2, pp38,
pJNK1/2 and their respective unphosphorylated proteins, and Tubulin as a loading control. Bar graphs represent normalized data for pSTAT3/
STAT3, pERK/ERK, pp38/p38, and pJNK/JNK, and presented as means ± SEM. (**: P ≤ 0.01) indicates significant difference between saline- and
cerulein-injected mice, and (#: P≤ 0.05; ##: P ≤ 0.01) indicates significant difference between WT and KO mice.
Bettaieb et al. Cell Communication and Signaling 2014, 12:13 Page 5 of 11
http://www.biosignaling.com/content/12/1/13and p50) and their translocation to the nucleus for the
activation of transcription [52]. Accordingly, we deter-
mined the activation status of components of NF-κB sig-
naling pathway in control and panc-TCPTP KO mice.
Cerulein-induced IKKα, IκBα and NF-κBp65 phosphoryl-
ation and NF-κBp50 expression were attenuated in panc-
TCPTP KO mice compared with controls (Figure 4).
These data demonstrate a decreased cerulein-induced
NF-κB inflammatory response in panc-TCPTP KO mice.
This is in keeping with the reduced pancreatic and circu-
lating pro-inflammatory cytokines evident in cerulein-
treated panc-TCPTP KO mice.
When the folding capacity of the ER is exceeded, mis-
folded proteins accumulate and lead to ER stress [53].
Cells use adaptive mechanisms to mitigate ER stress
known as the unfolded protein response (UPR) [54]. UPR
is triggered by transmembrane sensors such as PKR-like
ER-regulated kinase (PERK) that detect unfolded proteins
in the ER and convey information through their cytosolic
domain [55]. ER stress is implicated in the pathophysi-
ology of pancreatitis [56]. Further, we previously demon-
strated that TCPTP knockdown in the glucose-responsive
MIN6 β-cells attenuated PERK-eIF2α signaling [35]. In
line with these findings, pancreatic TCPTP deficiency at-
tenuated cerulein-induced PERK Thr980 and eukaryotic
translation initiation factor 2α (eIF2α) Ser51 phosphoryl-
ation compared with controls (Figure 5). The UPR is de-
ployed by cells as a compensatory mechanism to restorehomeostasis, but if it fails then apoptosis commences [57].
After exposure to apoptotic stimuli, cells activate initiator
Caspases (Caspases 8 and 9) that proteolytically cleave
and activate effector Caspases (Caspases 3 and 7) to dis-
mantle dying cells [58,59]. Accordingly, we assessed
cerulein-induced expression of initiator and effector
Caspases in control versus panc-TCPTP KO mice.
Cerulein caused pro-Caspases 8, 9 and 3 cleavage and
cleavage of poly ADP ribose polymerase (PARP)
(Figure 5). TCPTP deficiency decreased cleaved Caspase
8, 9 and 3 expression as well as PARP indicative of
decreased apoptosis (Figure 5). Collectively, these find-
ings demonstrate decreased inflammatory signaling, and
decreased ER stress and cell death upon pancreatic
TCPTP deficiency during the early phase of cerulein-
induced AP.
Discussion
The multistep development of AP involves a complex
cascade of local and systemic events that occur in re-
sponse to stress by the acinar cells, but the underlying
cellular and molecular mechanisms are not well under-
stood. In this study we investigated the role of TCPTP in
AP using a cerulein-induced mouse model. We demon-
strated increased TCPTP mRNA and protein expression
during the early phase of AP. Importantly, pancreatic
TCPTP deficiency in mice mitigated the effects of
cerulein-induced AP. At the molecular level, panc-
Figure 4 Regulation of cerulein-induced NF-κB inflammatory response by TCPTP. Total pancreas lysates from control without (n = 9) and
with (n = 12) cerulein, and panc-TCPTP KO without (n = 7) and with (n = 9) cerulein were immunoblotted for pIKKα, pIκBα, pNF-κB and their
respective unphosphorylated proteins, NF-κB1 p50, and Tubulin as a loading control. Bar graphs represent normalized data for pIKKα/IKKα, pIκBα/
IκBα, pNF-κB/NF-κB and NF-κB1 p50/Tubulin as means ± SEM. (**: P≤ 0.01) indicates significant difference between saline- and cerulein-injected
mice, and (#: P≤ 0.05; ##: P≤ 0.01) indicates significant difference between WT and KO mice.
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STAT3 tyrosyl phosphorylation, decreased NF-κB inflam-
matory response, and decreased ER stress and cell death.
These findings uncover a novel role for pancreatic
TCPTP and suggest that its pharmacological inhibition
may be of value for treating AP.
Alterations in gene and protein expression during the
initiation phase of AP play an important role in the de-
velopment and severity of the disease [60]. In this regard,
we report an increase in TCPTP expression in a cerulein-
induced AP mouse model. This model was employed
since secretagogue-induced pancreatitis, elicited by ad-
ministration of supramaximally stimulating dose of ceru-
lein, is the most well characterized of the pancreatitis
models and has characteristics that are similar to those of
human pancreatitis [8]. Using the cerulein-induced
model, it was demonstrated that the expression of the
SH2 domain containing phosphatases, SHP2 and SHP1
increased in AP in rats [16]. While the increase in SHP2
expression was observed in three different in vivo models
that of SHP1 was specific to the cerulein-induced model
[16]. In this study, we additionally confirmed the in-
creased expression of TCPTP using taurocholate-treated
rats thereby establishing that its expression pattern in
pancreatitis is not specific to one rodent model. Similar
to TCPTP, expression of the closely-related PTP1B was
increased in cerulein-induced pancreatitis in mice and
rats (Figure 1) [17], in contrast to the differentialexpression of these PTPs in the pancreata of mice after
chronic high fat feeding [35]. Cerulein administration
modulates pancreatic tyrosyl phosphorylation [14,15],
highlighting the relevance of this signaling modality to
pancreatitis and the need to further investigations on the
expression and activities of PTKs and PTPs during the
initiation and development of this disease. Further, SHP-
1, SHP-2 and PTP1B have all been implicated in the de-
phosphorylation and inactivation of JAK PTKs [61-63].
Thus, it would be of considerable interest to determine
whether the elevated SHP-1, SHP-2 and PTP1B act in
concert with TCPTP for the coordinated inactivation of
JAK/STAT3 signaling.
Using a genetic approach, we demonstrated that abla-
tion of TCPTP in the pancreas ameliorated the course of
AP as shown by the reduced serum amylase and lipase ac-
tivities, decreased pancreatic TNFα, IL-1β and IL-6 expres-
sion and decreased serum levels of TNFα and IL-6. These
pro-inflammatory cytokines play a pivotal role in the de-
velopment and severity of the disease [42-44,64]. TNFα
exacerbates acinar cell injury and is implicated in the
spread of the inflammatory cascade to other organs lead-
ing to subsequent systemic complications. In addition,
IL-1β plays an important role in the development of AP
and the inhibition of its production decreases the severity
of the disease. Moreover, IL-6 is a major mediator of the
acute-phase response and its levels correlate with the se-
verity of the disease. Suppression of these pro-
Figure 5 Regulation of cerulein-induced ER stress and apoptosis by TCPTP. Total pancreas lysates from control without (n = 9) and with
(n = 12) cerulein and panc-TCPTP KO without (n = 7) and with (n = 9) cerulein were immunoblotted for pPERK and peIF2α and their respective
unphosphorylated proteins, cleaved Caspases 8, 9 and 3, PARP and Tubulin as a loading control. Bar graphs represent normalized data for pPERK/
PERK, peIF2α/eIF2α and Caspase 8, 9, 3 and PARP/Tubulin as means ± SEM. (*: P≤ 0.05; **: P≤ 0.01) indicates significant difference between
saline- and cerulein-injected mice, and (#: P≤ 0.05; ##: P≤ 0.01) indicates significant difference between WT and KO mice.
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pancreatitis [65]. It remains unclear if the decreased ex-
pression of such pro-inflammatory cytokines in panc-
TCPTP KO mice may be associated with alterations in
the expression of anti-inflammatory cytokines such as
IL-10. Additional studies are warranted to determine the
effects of TCPTP deficiency on cytokines levels and the
progression of AP.
Pancreatic TCPTP deficiency modulated cerulein-
induced STAT3 phosphorylation, MAPK signaling and
the NF-κB inflammatory response. STAT3, a bona fide
TCPTP substrate [26,29], regulates the expression of
genes involved in inflammatory reactions induced in re-
sponse to tissue injury and infection [66]. Importantly,
genetic ablation of pancreatic STAT3 exacerbates the
course of cerulein-induced AP demonstrating a protective
effect of STAT3 against necrotizing pancreatitis [45].Thus, it is conceivable that the protective effects of pan-
creatic TCPTP deficiency in AP might be mediated, at
least in part, by increased STAT3 activation. However, it
is important to note that TCPTP deficiency impacted on
additional signaling pathways that have been implicated
previously in pancreatitis. In particular, pancreatic TCPTP
deletion correlated with decreased activation of the
MAPKs JNK, p38 and ERK1/2 indicative of decreased
cellular stress, and is in line with previous studies impli-
cating MAPKs in AP [67-70]. Moreover, the NF-κB in-
flammatory response, which plays an important role in
the early stages of AP pathogenesis [48-50] was also at-
tenuated in panc-TCPTP KO mice. The precise mechan-
ism by which TCPTP-deficiency attenuates MAPK and
NF-κB signaling remains unclear, but may be indirect and
related to overall reduction in inflammation. Finally, ER
stress has also been implicated in the pathophysiology of
Table 1 List of primers used to quantitate TCPTP, PTP1B,
SHP1, IL1-β, IL-6 and TNFα expression
Gene Forward 5′- > 3′ Reverse 5′- > 3′
IL-1β AGCTTCAGGCAGGCAGTATC AAGGTCCACGGGAAAGACAC
IL-6 ACAACCACGGCCTTCCCTACTT CACGATTTCCCAGAGAACATGTG
PTP1B AAGTTCATCATGGGCGACTC CTGTCTTCATCCCCACAGGT
SHP1 AGCTGGGTCCCAAGGAGTAT CTTGAGGGTAGAGGCCATGA
TBP TTGGCTAGGTTTCTGCGGTC GCCCTGAGCATAAGGTGGAA
TCPTP AGAGTGGCCAAGTTTCCAGA CACACCATGAGCCAGAAATG
TNFα GACGTGGAACTGGCAGAAGAG TGCCACAAGCAGGAATGAGA
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atic damage [56], whereas PERK-deficiency impacts on
the viability of the exocrine pancreas [71]. The attenuated
PERK-eIF2α phosphorylation and apoptosis observed
herein upon pancreatic TCPTP deficiency are in line with
our previous findings implicating STAT3 in the regulation
of the UPR in MIN6 cells [35] and likely contribute to the
attenuated cerulein-induced pancreatic damage.
Although our studies suggest that the targeted inhib-
ition of TCPTP in the pancreas may represent a plaus-
ible approach for combating AP, it is important to note
that TCPTP is generally considered to be a negative
regulator of the inflammatory response. Mice with a glo-
bal deficiency in TCPTP die soon after birth from
hematopoietic defects [31,72] and the development of
progressive systemic inflammatory disease [32]. More-
over, T cell-specific TCPTP KO mice develop an ef-
fector/memory T cell phenotype, inflammation and
autoimmunity with age [33], whereas TCPTP-deficient T
cells promote autoimmunity and colitis when transferred
into lymphopenic hosts [73]. These anti-inflammatory
effects of TCPTP have been linked with the dephosphor-
ylation of Src family kinases, including Lck to attenuate
T cell signaling [33], and c-Src to attenuate TNF signal-
ing [24], as well as the dephosphorylation of JAK1 and
JAK3 [25] and varied STAT family members such as
STAT1, STAT5 and STAT6 [25,27,28] to attenuate cyto-
kine signaling. To our knowledge the results described
in this study are the first to establish TCPTP’s capacity
to promote the inflammatory response. We suggest that
this occurs through the dephosphorylation of its sub-
strate STAT3 [26,29,30], which like TCPTP, acts in a
cell-type and tissue-dependent manner to elicit both
pro- and anti-inflammatory actions.
In summary, the results presented herein demonstrate
a novel role for TCPTP in acute pancreatitis and suggest
that interventions designed to specifically inhibit TCPTP
in the pancreas may be of value in treating this disease.
Methods
Animal studies
TCPTP-floxed (TCPTPfl/fl) mice on C57Bl/6J back-
ground were generated previously [33,34]. Pdx1-Cre mice
on C57Bl/6J background were provided by Dr. D. Melton
(Harvard University) [41]. Mice were maintained on a
12 h light-dark cycle in a temperature-controlled facility,
with free access to water and food. Mice were fed stand-
ard laboratory chow (Purina lab chow, # 5001) at wean-
ing. Genotyping for the TCPTP floxed allele and for the
presence of Cre was performed by polymerase chain re-
action (PCR), using DNA extracted from tails as previ-
ously described [33,34]. Acute pancreatitis was induced
in 6 week old control and panc-TCPTP KO mice. Mice
were fasted overnight then injected intraperiotoneally 12consecutive times, at 1 h intervals, with cerulein (50 μg/
kg body weight). DMSO was administered to the control
group of mice as a vehicle control for cerulein adminis-
tration. All animals were sacrificed 2 h after the last in-
jection and blood was collected to determine serum
amylase and lipase using ELISA kits (Sigma). Circulating
serum cytokines levels were measured using a Multiplex
kit from Meso Scale Discovery according to the manufac-
turer’s protocol. Pancreata were rapidly removed then
portions were allocated for histology, RNA analysis and
biochemistry. All mouse studies were conducted accord-
ing to federal guidelines and approved by the Institu-
tional Animal Care and Use Committee at University of
California Davis.
Male Wistar rats were placed under deep anaesthesia
with isoflurane before being treated with a solution of
3.5% sodium taurocholate in 0.9% sodium chloride.
Acute pancreatitis was induced by a retrograde infusion
of the solution before described. At 1 h, and 6 h after
the induction of acute pancreatitis, rats were anaesthe-
tized again and the pancreata were harvested and imme-
diately snap-frozen in liquid nitrogen. Wistar rats were
used in accordance with protocols approved by the Eth-
ical Committee for Animal Experimentation and Well-
being of the University of Valencia.
Biochemical analyses
Pancreata were lysed using radio-immunoprecipitation
assay (RIPA) buffer (10 mM Tris-HCl, pH: 7.4, 150 mM
NaCl, 0.1% sodium dodecyl sulfate [SDS], 1% Triton X-
100, 1% sodium deoxycholate, 5 mM EDTA, 1 mM NaF,
1 mM sodium orthovanadate and protease inhibitors).
Lysates were clarified by centrifugation at 13,000 rpm for
10 min, and protein concentrations were determined
using a bicinchoninic acid protein assay kit (Pierce
Chemical). Proteins were resolved by SDS-PAGE and
transferred to PVDF membranes. Immunoblotting of ly-
sates was performed with antibodies for PTP1B (Abcam),
TCPTP, SHP1, pPERK (Thr980), PERK, peIF2α (Ser51),
pSTAT3 (Tyr705), STAT3, eIF2α, cleaved Caspases 8, 9
and 3, Tubulin (Santa Cruz), pp38 (Thr180/Tyr182), p38,
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IKKα/β, pIκBα (Ser32), IκBα, pNF-κBp65 (Ser536), NF-
κBp65, NF-κBp50 (Cell signaling). After incubation with
appropriate secondary antibodies, proteins were visualized
using enhanced chemiluminescence (ECL, Amersham
Biosciences). Pixel intensities of immunoreactive bands
were quantified using ImageQuant 5.0 software (Molecular
Dynamics).
Total RNA was extracted from pancreata using TRIzol
reagent (Invitrogen). cDNA was generated using high-
capacity cDNA Archive Kit (SuperScriptTM III Reverse
Transcriptase, Invitrogen). TCPTP, PTP1B, SHP1, IL1-β,
IL-6 and TNFα were assessed by SYBR Green quantita-
tive real time PCR (iCycler, BioRad) using the ΔCT
method with appropriate primers (Table 1) and normal-
ized to TATA-Box binding protein (TBP).
Statistical analyses
Data are expressed as means ± standard error of the
mean (SEM). Single data point comparisons were per-
formed using Tukey’s-Kramer HSD analyses using JMP
program (SAS Institute). Differences were considered
significant at P ≤ 0.05 and highly significant at P ≤ 0.01.
Additional file
Additional file 1: Figure S1. PTP1B and SHP1 expression in panc-
TCPTP KO mice. Total pancreas lysates of wild type and panc-TCPTP KO
mice without (-) and with (+) cerulein administration immunoblotted for
PTP1B, SHP1, TCPTP and Tubulin. Bar graph represents expression of
PTP1B and SHP1 (normalized to Tubulin) and presented as means ± SEM.
(*; P < 0.05, **; P < 0.01) indicates significant difference between
saline- and cerulein-injected mice, and (#; P < 0.05) indicates significant
difference between WT and KO mice.
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